JOURNAL OF THE TURKISH-GERMAN GYNECOLOGICAL ASSOCIATION, vol.20, no.1, pp.31-36, 2019 (ESCI)
Objective: It is known that optimal or complete cytoreduction is the most important factor in patients with advanced ovarian cancer. The aim of this study was to examine the results of patients who did not undergo optimal cytoreduction and to examine subgroup analysis based on neoadjuvant chemotherapy (NAC).